Healthcare IT services have evolved to go beyond tech support, with companies offering a wider scope of services and greater expertise. The need for advanced IT support has increased due to the rising number of healthcare data breaches, ransomware attacks, and the growth of telehealth and administrative functions. IT partners now offer prevention-focused cybersecurity consulting,…
Irish-based scientists have developed a new surgical implant that could transform the treatment of complex bone infections. The material, similar to human bone, contains tiny copper nanoparticles to kill bacteria and a genetic molecule to stimulate bone growth. Preclinical lab tests showed that the implants could stimulate bone regrowth in two weeks and stop 80%…
Active transcranial direct-current stimulation (tDCS) has been found to reduce pain intensity in patients with fibromyalgia (FM), according to a study published in BMC Neurology. Previous studies have shown that tDCS can effectively reduce pain intensity in FM patients. An updated meta-analysis of 20 studies and 664 participants found that active tDCS was effective in…
A new study in Proceedings of the National Academy of Science discusses the role of the protein WASF3 in preventing ME/CFS patients from generating normal amounts of cellular energy. ME/CFS is a condition characterized by extreme fatigue and neurological concerns with no known cause. Research has shown that people with ME/CFS have high WASF3 levels…
Healthcare mergers and acquisitions are currently in a state of decline, reflecting in data that shows a substantial drop in dealmaking activity. However, there is increasing optimism among dealmakers that next year will bring a meaningful upswing in M&A activity. This is due to factors such as shrinking valuations, divestitures of non-core assets, changing dynamics,…
Kaiser Health News (KHN) is a nonprofit newsroom focused on health and health policy. They distribute their journalism for free and without advertising through media partners of all sizes. KHN appreciates all forms of engagement from their readers and listeners and welcome support. KHN is an editorially independent program of KFF (Kaiser Family Foundation). You…
Research on social determinants of health for children and young adults with leukemia and lymphoma is necessary to improve care, as these factors impact outcome disparities for patients with hematological malignancies. Access to novel therapies, such as immunotherapies, targeted treatments, and diagnostics, is a significant issue, and disparities are driven by systemic racism and historic…
The Food and Drug Administration approved the first gene therapies for sickle cell disease. The approval sparked discussions at the American Society of Hematology meeting, where doctors and researchers expressed measured optimism about the landmark shift in the treatment of the disease. However, questions were raised about whether these innovative treatments will reach the patients…
The European Medicines Agency (EMA) is conducting a review of GLP-1 receptor agonists, including Ozempic, Saxenda, and Wegovy, used to treat type 2 diabetes and weight management, after reports of suicidal ideation and self-harm. The review was prompted by the Icelandic Medicines Agency following reports of these issues in people using liraglutide and semaglutide. The…
Researchers at the University of California San Diego have developed a smartphone attachment to measure changes in pupil size, useful for neurological conditions. This helps people with darker skin tones, who were previously underserved by available technology. The attachment fits over a smartphone camera and uses far-red light to capture images of the iris and…
